EUS-guided histological specimens from the pancreatic cyst wall can be obtained through a through-the-needle microbiopsy forceps, although the value of this instrument has not yet been tested in a multicentre clinical setting. In the presented study, patients referred for EUS evaluation of pancreatic cysts in whom EUS-guided microbiopsy was attempted (n=28) were included from 6 tertiary centres.
The technical success rate was 85.7% (n=24). Biopsies were generally of good quality and contributed to the diagnosis in 20 patients (clinical success of 71.4%). Only 3 adverse events were recorded (10.7%). Technical failure seems to be caused by loss of flexibility of the echoendoscope when both forceps and the FNA needle are inserted. Other technical difficulties described did not hinder procurement of the specimens. Failures were seen in locations where EUS-guided puncture is known to be challenging (i.e. when the echoendoscope was placed in the duodenum). The majority of the procedures was performed using a flexible nitinol needle (n=18/28), but no firm conclusions can be drawn on the potential role of needle flexibility in the ability to obtain biopsy samples with the microbiopsy forceps. Even though no severe or fatal adverse events were recorded, a rate of 10.7% is notable and should be interpreted with caution due to the limited number of patients.
It was concluded that the use of the microbiopsy forceps is feasible with acceptable rates of technical and clinical success across centres. However, the occurrence of adverse events may preclude routine incorporation of this method, and it may be most appropriate to apply only to patients with uncertain cystic lesions where surgery is considered, as these might benefit from this form of extended diagnostics. Prospective studies are warranted to determine the diagnostic potential compared with other modalities.
- Kovacevic B, et al. UEG Week 2019, Abstract LB10.
Posted on
Previous Article
« Metal stents are better than plastic for endoscopic biliary drainage Next Article
Locally active corticosteroid promising in eosinophilic oesophagitis »
« Metal stents are better than plastic for endoscopic biliary drainage Next Article
Locally active corticosteroid promising in eosinophilic oesophagitis »
Table of Contents: UEGW 2019
Featured articles
Interview with UEG President Prof. Paul Fockens
Upper GI Disorders
Locally active corticosteroid promising in eosinophilic oesophagitis
First-in-human radiofrequency vapor ablation in Barrett’s oesophagus
Irritable Bowel Syndrome
Faecal microbiota transplantation is effective for irritable bowel syndrome
Human milk oligosaccharides improve IBS symptoms
Inflammatory Bowel Disease
Ustekinumab is safe and effective in ulcerative colitis: 2-year data
Decreased microvilli length in CD patients
Phase 2 data shows benefit for mirikizumab in CD patients
Subcutaneous ustekinumab as maintenance therapy in UC
First evidence of long-term efficacy of ABX464 in ulcerative colitis
New treatment may reverse coeliac disease
IBD prevalence 3 times higher than estimated and expected to rise
Microbiome and Microbiota
Early stages of gastric metaplasia: molecular profiling
Plant-based foods and Mediterranean diet associated with healthy gut microbiome
Antibiotic resistance in H. pylori has doubled over last 20 years
Pancreatitis
New model predicts recurrence of acute biliary pancreatitis
Hepatology
Restrictive strategy for cholecystectomy selection does not reduce pain, but does reduce surgery
β-blockers may halt cirrhosis progression: PREDESCI trial
Obeticholic acid prevents liver fibrosis from NASH
Oncology
Metal stents are better than plastic for endoscopic biliary drainage
Ramosetron relieves low anterior resection syndrome
Immunonutrition during neoadjuvant oesophagogastric cancer therapy: no benefit
Endoscopy
EUS-guided histological specimens from the pancreatic cyst wall
Digital single-operator cholangioscopy more sensitive than endoscopic retrograde cholangiopancreatography
New single-use duodenoscope well-liked by endoscopists
Related Articles
October 23, 2019
IBD prevalence 3 times higher than estimated and expected to rise
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com